Related Experiment Video
Updated: Jul 9, 2026
09:39
Creation of Reversible Cholestatic Rat Model
Published on: May 21, 2011
Drug- and chemical-induced cholestasis
1Department of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
Clinics in Liver Disease
|April 9, 2001
Summary
Drug-induced cholestasis is a growing cause of liver disease, presenting diverse injuries like jaundice and hepatitis. Recognizing these patterns is crucial for patient care when drug-induced liver injury is suspected.
Area of Science:
- Hepatology
- Clinical Medicine
- Toxicology
Background:
- Drug-induced cholestasis is an emerging cause of liver disease.
- It presents a wide spectrum of clinical and pathological liver injuries.
- These injuries can mimic other serious liver conditions.
Purpose of the Study:
- To highlight the significance of drug-induced cholestasis.
- To describe the varied presentations of drug-induced liver injury.
- To emphasize the importance of recognizing these injuries in clinical practice.
Main Methods:
- Literature review of drug-induced cholestasis.
- Analysis of clinical and pathological features.
- Comparison with other liver diseases.
Main Results:
- Drug-induced cholestasis encompasses jaundice, cholestatic hepatitis, and bile duct injury.
- These injuries can resemble primary biliary cirrhosis and sclerosing cholangitis.
- Fatal outcomes from drug-induced cholestasis are rare but possible.
Conclusions:
- Clinicians must recognize drug-induced cholestasis in patients with jaundice.
- Understanding the spectrum of injury aids in diagnosis and management.
- Awareness is key when patients present with liver disease and are on medication.
Related Concept Videos
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...